Filing Details

Accession Number:
0000014272-21-000226
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-24 17:25:14
Reporting Period:
2021-11-22
Accepted Time:
2021-11-24 17:25:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
14272 Bristol Myers Squibb Co BMY Pharmaceutical Preparations (2834) 220790350
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1524143 Paul Autenried Von Bristol-Myers Squibb Company
430 E. 29Th Street, 14 Floor
New York NY 10016
Evp, Chief Information Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.10 Par Value Disposition 2021-11-22 18,363 $57.17 96,307 No 4 S Indirect Trust
Common Stock, $0.10 Par Value Disposition 2021-11-23 15,418 $57.47 80,889 No 4 S Indirect Trust
Common Stock, $0.10 Par Value Disposition 2021-11-24 17,353 $56.92 63,536 No 4 S Indirect Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Trust
No 4 S Indirect Trust
No 4 S Indirect Trust
Footnotes
  1. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $57.16 to $57.18, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  2. Shares held in a Spousal Lifetime Access Trust (SLAT).
  3. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $57.47 to $57.48, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  4. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $56.91 to $56.93, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.